Article Figures & Tables
Figures
- Figure 1:
Number of brand-name and generic bisphosphonate prescriptions dispensed from pharmacies to patients aged 65 years and older who lived in the community. ALN = alendronate, vitD3 = vitamin D3, RSD = risedronate, DR = delayed release, Ca = calcium.
- Figure 2:
Number of brand-name and generic bisphosphonate prescriptions dispensed from pharmacies to patients aged 65 years and older who lived in a long-term care facility. ALN = alendronate, vitD3 = vitamin D3, RSD = risedronate, DR = delayed release, Ca = calcium.
Tables
- Table 1: Dates when the generic bisphosphonates were first dispensed in Ontario by the ODB formulary
Generic bisphosphonate Date Daily alendronate Sept. 2003 Weekly alendronate July 2005 Daily risedronate Apr. 2010 Weekly risedronate Apr. 2010 Monthly risedronate June 2012 Weekly alendronate + vitamin D Jan. 2014 Note: ODB = Ontario Drug Benefit.
- Table 2: Percentage of generic oral bisphosphonates of the total dispensed by ODB in the 3 months following formulary availability
Generic bisphosphonate Percentage of total drugs dispensed to patients in the community Percentage of total drugs dispensed to patients in long-term care facilities 1st mo 2nd mo 3rd mo 1st mo 2nd mo 3rd mo Daily alendronate 59 67 81 48 83 88 Weekly alendronate 43 88 95 47 93 98 Daily risedronate 15 73 85 7 37 83 Weekly risedronate 18 91 96 18 96 99 Monthly risedronate 13 86 93 6 84 95 Weekly alendronate + vitamin D 51 80 90 64 95 99 Note: ODB = Ontario Drug Benefit.
In this issue
Article tools
Respond to this article
Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive study
Related Articles
Cited By...
- No citing articles found.